SNSE
Price:
$0.609
Market Cap:
$15.32M
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the tre...[Read more]
Industry
Biotechnology
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
SNSE
According to Sensei Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.52. This represents a change of -21.39% compared to the average of -0.66 of the last 4 quarters.
The mean historical PE Ratio of Sensei Biotherapeutics, Inc. over the last ten years is -10.67. The current -0.52 PE Ratio has changed 387.56% with respect to the historical average. Over the past ten years (40 quarters), SNSE's PE Ratio was at its highest in in the June 2024 quarter at -0.52. The PE Ratio was at its lowest in in the December 2020 quarter at -17.41.
Average
-10.67
Median
-2.64
Minimum
-29.18
Maximum
-0.57
Discovering the peaks and valleys of Sensei Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.84%
Maximum Annual PE Ratio = -0.57
Minimum Annual Increase = -84.69%
Minimum Annual PE Ratio = -29.18
Year | PE Ratio | Change |
---|---|---|
2023 | -0.57 | -39.48% |
2022 | -0.94 | -78.15% |
2021 | -4.29 | -84.69% |
2020 | -28.02 | -3.96% |
2019 | -29.18 | 2.84% |
The current PE Ratio of Sensei Biotherapeutics, Inc. (SNSE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.93
5-year avg
-12.60
10-year avg
-10.67
Sensei Biotherapeutics, Inc.’s PE Ratio is greater than Landos Biopharma, Inc. (-5.74), greater than Vor Biopharma Inc. (-0.53), greater than Evaxion Biotech A/S (-1.23), greater than Decibel Therapeutics, Inc. (-1.94), less than NexImmune, Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
-5.74 | $71.68M | |
-0.53 | $62.11M | |
-1.23 | $18.67M | |
-1.94 | $123.37M | |
-0.00 | $711.28K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sensei Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sensei Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sensei Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Sensei Biotherapeutics, Inc. (SNSE)?
What is the highest PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
What is the 3-year average PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
What is the 5-year average PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
How does the current PE Ratio for Sensei Biotherapeutics, Inc. (SNSE) compare to its historical average?